Abstract Carbohydrate antigen 19-9 (CA 19-9) is a cell surface glycoprotein complex most
commonly associated with pancreatic ductal adenocarcinoma (PDAC). Koprowski first …

Background This systematic review aimed to assess the diagnostic accuracy of the
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …

Background & Aims There is substantial interest in liquid biopsy approaches for cancer early
detection among subjects at risk, using multi-marker panels. CA19-9 is an established …

Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early
stages with enhanced screening methods is vital as metastases and recurrences increase …

Background Detecting cancer at early stages significantly increases patient survival rates.
Because lethal solid tumors often produce few symptoms before progressing to advanced …

Pancreatic ductal adenocarcinoma (PDAC) is frequently detected in late stages, which leads
to limited therapeutic options and a dismal overall survival rate. To date, no robust method …

Cancer markers are molecules produced by cancer cells which may serve to identify the
presence of cancer. Cancer markers can be differentiated as serum-based, radiology-based …

Pancreatic cancer is a lethal condition with a rising incidence and often presents at an
advanced stage, contributing to abysmal five-year survival rates. Unspecific symptoms and …

Abstract Purpose: CA19–9 synthesis is influenced by common variants in the
fucosyltransferase (FUT) enzymes FUT3 and FUT2. We developed a clinical test to detect …

Pancreatic ductal adenocarcinoma (PDAC) is rapidly becoming one of the leading causes of
cancer-related deaths in the United States, and with its high mortality rate, there is a …